Monoamine oxidase inhibitors (MAOI) are regarded to extend and greatly enhance the effects of dimethyltryptamine (copyright) and just one study assumed which the impact on psilocybin can be similar since it is often a structural analogue of copyright.[one hundred forty five] However, only a small portion of psilocin seems to get metabolized by MAO.